Vergleich

Phospho-ERBB2(S728) Blocking Peptide

ArtNr ABC-BP3781p
Hersteller Abcepta
Menge 500 ug
Kategorie
Typ Peptides
Format Lyophilized
Specific against other
Citations Geradts, J., et al. Cancer Invest. 28(9):969-977(2010)
Zaoui, K., et al. Proc. Natl. Acad. Sci. U.S.A. 107(43):18517-18522(2010)
Oliveras, G., et al. Ann. N. Y. Acad. Sci. 1210, 86-92 (2010) :
Han, J.S., et al. Anticancer Res. 30(9):3407-3412(2010)
Stackievicz, R., et al. Isr. Med. Assoc. J. 12(5):290-295(2010)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340, ERBB2, HER2, MLN19, NEU, NGL
Similar products ERBB2, Receptor tyrosine-protein kinase erbB-2, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, p185erbB2, Tyrosine kinase-type cell surface receptor HER2, MLN 19, HER2, NEU, NGL, MLN19, Metastatic lymph node gene 19 protein, CD340
Lieferbar
Primary Accession
P04626
Bio Background
This gene encodes a member of the epidermal growth factor
(EGF) receptor family of receptor tyrosine kinases. This protein
has no ligand binding domain of its own and therefore cannot bind
growth factors. However, it does bind tightly to other ligand-bound
EGF receptor family members to form a heterodimer, stabilizing
ligand binding and enhancing kinase-mediated activation of
downstream signalling pathways, such as those involving
mitogen-activated protein kinase and phosphatidylinositol-3 kinase.
Allelic variations at amino acid positions 654 and 655 of isoform a
(positions 624 and 625 of isoform b) have been reported, with the
most common allele, Ile654/Ile655, shown here. Amplification and/or
overexpression of this gene has been reported in numerous cancers,
including breast and ovarian tumors. Alternative splicing results
in several additional transcript variants, some encoding different
isoforms and others that have not been fully characterized.
Bio References
Geradts, J., et al. Cancer Invest. 28(9):969-977(2010)
Zaoui, K., et al. Proc. Natl. Acad. Sci. U.S.A. 107(43):18517-18522(2010)
Oliveras, G., et al. Ann. N. Y. Acad. Sci. 1210, 86-92 (2010) :
Han, J.S., et al. Anticancer Res. 30(9):3407-3412(2010)
Stackievicz, R., et al. Isr. Med. Assoc. J. 12(5):290-295(2010)
Gene ID
2064
Gene Name
ERBB2
Subtitle
Synthetic peptide
Other Accession
P06494; NP_001005862.1
Target/Specificity
The synthetic peptide sequence is selected from aa 721-735 of HUMAN ERBB2

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen